NCT00657319
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Budapest, Hungary
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,994 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00838903
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Dothan, Alabama, United States
- GSK Investigational Site Hueytown, Alabama, United States
Completed
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
NCT00839527
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
Completed
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes
NCT00838916
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Dothan, Alabama, United States
NCT00665093
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Skopje, North Macedonia
NCT02269098
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +14 more
- Locations
-
- MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
NCT00849056
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
NCT00696995
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Lahti, Finland
NCT00318786
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT01487798
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Bolton, United Kingdom
- Novo Nordisk Investigational Site Cardiff, United Kingdom
- Novo Nordisk Investigational Site Derby, United Kingdom
- Novo Nordisk Investigational Site Dundee, United Kingdom